Australia markets closed

Evome Medical Technologies Inc. (LNDZF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.21000.0000 (0.00%)
At close: 01:45PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 11.50M
Enterprise value 28.82M
Trailing P/E 20.45
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.34
Price/book (mrq)5.68
Enterprise value/revenue 0.46
Enterprise value/EBITDA -3.43

Trading information

Stock price history

Beta (5Y monthly) 1.90
52-week change 3-19.23%
S&P500 52-week change 322.38%
52-week high 30.3150
52-week low 30.0210
50-day moving average 30.1863
200-day moving average 30.1676

Share statistics

Avg vol (3-month) 3920
Avg vol (10-day) 3N/A
Shares outstanding 557.83M
Implied shares outstanding 692.92M
Float 848.81M
% held by insiders 116.32%
% held by institutions 19.81%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 314 Dec 2020
Ex-dividend date 424 May 2017
Last split factor 20.737:1
Last split date 315 Dec 2020

Financial highlights

Currency in CAD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -26.01%
Operating margin (ttm)-17.90%

Management effectiveness

Return on assets (ttm)-31.11%
Return on equity (ttm)-161.40%

Income statement

Revenue (ttm)59.99M
Revenue per share (ttm)0.82
Quarterly revenue growth (yoy)36.50%
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)-15.6M
Diluted EPS (ttm)-0.1500
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)918.68k
Total cash per share (mrq)0.01
Total debt (mrq)24.69M
Total debt/equity (mrq)616.76%
Current ratio (mrq)0.56
Book value per share (mrq)0.05

Cash flow statement

Operating cash flow (ttm)-918.91k
Levered free cash flow (ttm)N/A